Marjorie A. Speers, PhD, is executive director of Clinical Research Pathways writes, (excerpted) Clinical trials conducted today in the United States lean heavily toward populations that are 80-90 percent white, as reported in a recent Scientific American editorial....
Results Are Expected to Prompt Changes in Practice, Improve Patient Outcomes Three studies being presented today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego offer more targeted solutions for managing CLL and multiple...
Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) today announced that it has passed the 50 percent enrollment point in its first pivotal Phase 3 clinical trial of RP-G28 for the potential treatment of LI, a study known as the “Liberatus” study. “We are pleased to have...
New tools and approaches poised to improve diagnostics and care for millions worldwide Four late-breaking studies being presented today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego offer groundbreaking solutions to...
Sixgill, LLC, the leader in sensor data services for governing Internet of Everything (IoE) assets, today announced Litmus Health will adopt Sixgill Integrity to provide blockchain data accuracy and consistency for its clinical data science platform. The combination...
Email
Text